marilyn-nieves-1
12 October 2017Americas

Allergan documents due to address patent ‘sham’ question

Allergan has until tomorrow, Friday October 13, to address the question of whether its patent licensing deal with a Native American tribe was a sham.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
16 October 2017   The Saint Regis Mohawk Tribe has launched a fierce defence of its patent licensing deal with Allergan, giving the Senate Judiciary Committee six main reasons which justify the agreement.

More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
16 October 2017   The Saint Regis Mohawk Tribe has launched a fierce defence of its patent licensing deal with Allergan, giving the Senate Judiciary Committee six main reasons which justify the agreement.

More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
16 October 2017   The Saint Regis Mohawk Tribe has launched a fierce defence of its patent licensing deal with Allergan, giving the Senate Judiciary Committee six main reasons which justify the agreement.